Mielóma multiplex: vizsgálatok itt: Olaszország
74 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Where
- Bologna, Milan, Naples, Rozzano, Torino
- Életkor
- 18 év and over
- People
- 508 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391657 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini, Varese
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - No phaseTaking peopleA "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
- Where
- Ancona, Bari, Bologna, Brescia, Catania, Florence, Genova, Milan, Monza, Naples, Novara, Parma, Pavia, Rimini, Roma, San Giovanni Rotondo, Terni, Torino, Udine, Varese
- Életkor
- 18 év and over
- People
- 1900
- Run by
- Fondazione EMN Italy Onlus
See details and how to joinNCT05001087 - No phaseNot yet taking people in OlaszországValidating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"
- Where
- Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia, Rome
- Életkor
- 18 év and over
- People
- 92
- Run by
- Fondazione EMN Italy Onlus
See details and how to joinNCT07746232 - 3. fázisNot yet taking people in OlaszországA trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
- Where
- Bologna, Milan, Rome, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 234 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524014-29-00 · EU 2025-524014-29-00 - 1. fázisNot yet taking people in OlaszországA Phase 1 Study of TT125-802 as Monotherapy and in Combination with Pomalidomide and Dexamethasone in Participants with Multiple Myeloma
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 25 worldwide
- Run by
- TOLREMO therapeutics AG
See details and how to join2025-523536-39-00 · EU 2025-523536-39-00 - No phaseTaking peopleA Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo, Roma, Salerno, Treviso, Trieste, Verbania, Vicenza
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318 - 1. fázisTaking peopleA study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractory Multiple Myeloma (CAMMA 3)
- Where
- Bologna, Rozzano
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Genentech Inc.
See details and how to join2023-503404-89-00 · EU 2023-503404-89-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Bologna, Catania, Genoa, Meldola, Milan, Monza, Rome
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 3. fázisTaking peopleMagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Where
- Ancona, Bologna, Florence, Legnano, Meldola, Milan, Palermo, Pescara, Pisa, Turin
- Életkor
- 18 év and over
- People
- 492 worldwide
- Run by
- Pfizer
See details and how to joinNCT06152575 · EU 2023-507871-23-00 - No phaseTaking peopleReal-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Chieti
- Életkor
- 18 év and over
- People
- 60
- Run by
- Università degli Studi 'G. d'Annunzio' Chieti e Pescara
See details and how to joinNCT07777406 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Bologna, Milan, Rome
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - 1. fázisTaking peopleLong-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Where
- Milan
- People
- 7 worldwide
- Run by
- USWM Ct LLC
See details and how to join2024-513033-21-00 · EU 2024-513033-21-00 - 3. fázisTaking peopleStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Bologna, Milan, Rome, Rozzano, Torino
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 3. fázisTaking peopleA trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.
- Where
- Bologna, Milan, Naples, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 153 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523285-25-00 · EU 2025-523285-25-00 - 2. fázisTaking peopleA multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
- Where
- Bari, Bergamo, Florence, Genoa, Meldola, Messina, Novara, Padova, Parma, Pavia, Pescara, Udine
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to join2023-505775-70-00 · EU 2023-505775-70-00 - 3. fázisNot yet taking people in OlaszországA Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
- Where
- Meldola
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- AbbVie
See details and how to joinNCT07728188 · EU 2026-525596-11-00 - No phaseNot yet taking people in OlaszországINfections in Patients Treated With CAR-T
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 290
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07713511 - 1/2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Where
- Bergamo, Meldola, Milan, Naples, Ravenna, Turin
- Életkor
- 18 év and over
- People
- 88 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-525105-20-00 · EU 2025-525105-20-00 - 2. fázisTaking peopleA Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- Where
- Alexandria, Ascoli Piceno, Genoa, Meldola, Milan, Pavia, Ravenna
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06140524 · EU 2023-505242-25-00 - No phaseTaking peopleAnonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 600
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07283224 - No phaseTaking peopleMMAPPIN' Study: Multiple Myeloma Analysis For Patient-specific Insights to Dissect Disease Heterogeneity
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 520
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07582354 - Korai 1. fázisTaking peopleSingle Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
- Where
- Naples
- Életkor
- 18 év and over
- People
- 10
- Run by
- National Cancer Institute, Naples
See details and how to joinNCT07577206 · EU 2024-513303-14-00 - No phaseTaking peopleOne Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
- Where
- Pavia
- Életkor
- 18 év to 99 év
- People
- 100
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07448935 - No phaseTaking peopleIntegrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
- Where
- Bologna, Catania, Palermo, Reggio Emilia
- Életkor
- 18 év and over
- People
- 60
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07214324